Analyst Ratings for Marker Therapeutics (MRKR) [Buys]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
3/25/2021 | Piper Sandler » Updated 5/31/2022 |
Joseph Catanzaro | New Coverage | Overweight (N/A) |
1.50 (3.50) |
2.58 (4.43) |
71.71% | Details |
3/19/2021 | Cantor Fitzgerald | Kristen Kluska | New Coverage | Overweight (N/A) |
6.00 (N/A) |
1.88 (4.43) |
135.64% | Details |